EPR Effect-Based Tumor Targeted Nanomedicine

• Beste egile batzuk: Maeda, Hiroshi (Argitaratzailea)
• Formatua: Baliabide elektronikoa Liburu kapitulua
• Hizkuntza: ingelesa
• Argitaratua: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
• Gaiak: Medicine; Oncology; extracellular matrix; drug delivery; tumor; cancer; targeting; reactive oxygen species; antioxidant; self-assembling drug; HPMA copolymers; EPR effect; controlled release; nanomedicines; nanoparticles; tumor vascular regulation; angiogenesis; blood perfusion; vascular permeability; tumor targeting; photodynamic; hyaluronan; zinc protoporphyrin; enhanced permeability and retention effect; cancer therapy; nanotechnology; tumor-selective drug delivery; photodynamic therapy; boron neutron capture therapy; isosorbide dinitrate; sildenafil citrate; EPR-effect enhancers; heterogeneity of the EPR effect; nitric oxide donors; tumor blood flow; TNBC; dasatinib; poly(styrene-co-maleic acid) micelles; nanoformulation; metabolism; EPR; nanomedicine; targeted therapy; solid cancer; microenvironment; hypoxia; DDS; anaerobic bacteria; Bifidobacterium; bacterial therapy; iDPS; EPR-based therapy; passive targeting; heterogeneity; solid-tumor; EPR-imaging techniques; sildenafil; phosphodiesterase 5 inhibitors; drug repurposing; chemoadjuvant; arterial infusion; canine cancer; particle beam therapy; proton beam therapy; carbon-ion beam therapy; combination therapy; iNaD; siRNA; microRNA; calcium phosphate; PEG blending; cancer treatment; n/a
• Sarrera elektronikoa: DOAB: download the publication; DOAB: description of the publication

I am honored to undertake the work for Guest Editor for this Special Issue of EPR Effect-Based Tumor Targeted Nanomedicine for the Journal of Personalized Medicine. It has already been 35 years since we published the concept of the EPR effect for the first time. The discovery of the new concept of E...